This bill (the “Health Over Wealth Act”) would impose new rules for for‑profit companies that own hospitals, clinics, nursing homes, and other health care providers. It requires large new public reporting about ownership, debt, fees, staffing, closures, and political spending; gives the Health and Human Services (HHS) Secretary power to require financial safeguards for private‑equity‑owned firms; and adds new review, licensing, enforcement, and bankruptcy rules aimed at protecting health care access and quality. The stated policy goal is to increase transparency and reduce harms from private equity and consolidation in health care.
Key changes:
Patients and communities
Hospitals and health systems (for‑profit)
Private equity firms and other investors
Health care workers and labor organizations
State and local governments
Regulators and courts
No publicly available information.
The bill appears intended to:
One concern is that the bill may create large new reporting and compliance burdens:
Bills on related subjects, starting with the United States.
Requires public reporting and licensing of for-profit health care owners, with safeguards on service closures, staffing, and investments; empowers HHS to set rules and review deals affecting patient access.
Status
Introduced
Requires health insurers and Medicare Advantage plans to publish yearly, deidentified data on denials, approvals, appeals, and prior-authorization lists, with standard definitions and public access.
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Requires HHS to study and publish annual State-level data on health care competition and consolidation for 10 years.
Status
Referred to the House Committee on Energy and Commerce.
Hospitals, labs, insurers must publish price data and provide real-time cost estimates to help consumers compare care costs.
Status
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 45 - 0.